Approximately 75% of breast cancers are positive for estrogen receptor (ER) and/or progesterone receptor (PR), where ER-positive tumors express ER, PR, ER-responsive elements or other genes that encode proteins of luminal epithelial cells, and therefore were termed the luminal group [55]. The gene discussed is ESR1; the disease is breast carcinoma.